Delivery Order SPE2DR25D1100-SPE2DR26FCW2B
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency (DLA) on May 2, 2025, for the supply of Restasis 0.05% Eye Emulsion in 30-count units. This firm fixed price delivery order, valued at $1,117.80, represents a non-set-aside competitive award and is scheduled for completion by May 5, 2025. The contract will be performed at the vendor's Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Restasis 0.05% eye emulsion in 60-count units. This non-competitive delivery order, valued at $11,404.78, was executed on October 20, 2025, with an ultimate completion date of October 21, 2025. The contract employs firm fixed pricing and represents a direct fulfillment of pharmaceutical needs within the...
- The Defense Logistics Agency awarded a $3,930.90 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30 single-dose units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price, non-set-aside contract issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $1,649.50 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (60-count units) with a firm fixed price contract type. The award was made on December 19, 2025, with an ultimate completion date of December 22, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $21,962.40 to supply Restasis 0.05% Eye Emulsion in 60-unit quantities. This contract, which was competitively awarded without set-aside restrictions, has a firm fixed price structure with an ultimate completion date of November 19, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a $1,293.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (60-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $35,696.28 to AmerisourceBergen Drug Corp for the supply of Restasis 0.05% Eye Emulsion in 60-unit quantities. This competitively awarded, firm fixed price delivery order has an ultimate completion date of July 11, 2025, and represents a non-set-aside procurement. The award to AmerisourceBergen's corporate office, located in Conshohocken, Pennsylvania, reflects the company's established role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $2,178.96 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% Eye Emulsion (30 count) with a firm fixed price and an ultimate completion date of December 15, 2025. This is a non-set-aside competitive award, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,117.68 delivery order to AmerisourceBergen Drug Corp for Restasis 0.05% eye emulsion (60 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Restasis 0.05% Eye Emulsion in 60-count units, with a contract ceiling value of $22,836.31. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award selection. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. This delivery order...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCW2BDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,010.08 to supply Restasis 0.05% Eye Emulsion in 30-unit quantities, with performance in Conshohocken, Pennsylvania and a completion date of December 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed-price pricing and operates as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, maintains a significant presence in federal medical procurement and serves critical defense health acquisition needs through the DLA Medical Supply Chain. The company's extensive contract portfolio with the Defense Logistics Agency demonstrates its capability to meet federal procurement requirements through open competition and its versatility in fulfilling diverse medical supply needs ranging from small-value transactions to orders exceeding $45,000. The DLA Troop Support plans to establish next-generation Pharmaceutical Prime Vendor Global Program contracts with multiple regional awards, positioning AmerisourceBergen to continue supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contracting vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 12/21/25 |